喜炎平超声雾化吸入治疗成人急性上呼吸道感染疗效观察

Clinical Observation of Xiyanping Ultrasonic Nebulization Therapy for Treatment of Adult Acute Upper Respiratory Infection

目的:观察喜炎平超声雾化吸入治疗成人急性上呼吸道感染的疗效。方法:将成人急性上呼吸道感染患者325例随机分为3组:利巴韦林雾化组92例,喜炎平静脉滴注组103例,喜炎平雾化组130例。3组患者均在给予常规退热及对症处理的基础上进行对应治疗。观察3组治疗后临床疗效及不良反应。结果:利巴韦林雾化组总有效率为64.1%,喜炎平静脉滴注组为80.6%,喜炎平雾化组为92.3%,3组比较,差异均有显著性意义(P<0.05),喜炎平雾化组总有效率优于利巴韦林雾化组和喜炎平静脉滴注组,喜炎平静脉滴注组优于利巴韦林雾化组。利巴韦林雾化组不良反应率为7.6%,喜炎平静脉滴注组为14.6%,喜炎平雾化组为6.2%,喜炎平静脉滴注组不良反应发生率最高,高于利巴韦林雾化组和喜炎平雾化组(P<0.05)。结论:喜炎平超声雾化吸入治疗成人急性上呼吸道感染的疗效显著。

Objective：To inves tigate the clinical effect of Xiyanping ultras onic nebulization therapy on treating adult acute upper res piratory infection. Methods：Three hundred and twenty- five patients were divided into three groups,92 patients in ribavirin ultras onic nebulization group, 103 patients in Xiyanping intravenous drip group, and 130 patients in Xiyanping ultras onic nebulization group. All of the three groups were given the corres ponding treatment on the bas is of conventional anti- pyretolys is and s ymptomatic treatment. The clinical effect and advers e reaction were obs erved after treatment. Results： The total effective rate was 64.1% in ribavirin ultras onic nebulization group,80.6% in Xiyanping intravenous drip group,and 92.3% in Xiyanping ultras onic nebulization group,the difference being s ignificant（P〈0.05）. The incidence of advers e reaction was 7.6% in ribavirin ultras onic nebulization group, 14.6% in Xiyanping intravenous drip group, and 6.2% in Xiyanping ultras onic nebulization group,the difference being s ignificant（P〈0.05）. Conclusion：Xiyanping ultras onic nebulization therapy is effective in treating acute upper res piratory infection.